PROMIS Physical Function for prediction of postoperative pain, narcotics consumption, and patient-reported outcomes following minimally invasive transforaminal lumbar interbody fusion

被引:27
|
作者
Patel, Dil, V [1 ]
Bawa, Mundeep S. [1 ]
Haws, Brittany E. [1 ]
Khechen, Benjamin [1 ]
Block, Andrew M. [1 ]
Karmarkar, Sailee S. [1 ]
Lamoutte, Eric H. [1 ]
Singh, Kern [1 ]
机构
[1] Rush Univ, Med Ctr, Dept Orthopaed Surg, Chicago, IL 60612 USA
关键词
Patient-Reported Outcomes Measurement Information System; Physical Function; minimally invasive transforaminal lumbar interbody fusion; patient-reported outcomes; pain scores; narcotics consumption; OSWESTRY DISABILITY INDEX; CAT INSTRUMENTS; SPINE SURGERY; SENSITIVITY;
D O I
10.3171/2018.9.SPINE18863
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
OBJECTIVE This study aimed to determine if the preoperative Patient-Reported Outcomes Measurement Information System, Physical Function (PROMIS PF) score is predictive of immediate postoperative patient pain and narcotics consumption or long-term patient-reported outcomes (PROs) following minimally invasive transforaminal lumbar interbody fusion (MIS TLIF). METHODS A prospectively maintained database was retrospectively reviewed. Patients who underwent primary, single-level MIS TLIF for degenerative pathology were identified and grouped by their preoperative PROMIS PF scores: mild disability (score 40-50), moderate disability (score 30-39.9), and severe disability (score 20-29.9). Postoperative pain was quantified using the visual analog scale (VAS), and narcotics consumption was quantified using Oral Morphine Equivalents. PROMIS PF, Oswestry Disability Index (ODI), 12-Item Short-Form Health Survey, Physical Component Summary (SF-12 PCS), and VAS back and leg pain were collected preoperatively and at 6-week, 3-month, 6-month, and 12-month follow-up. Preoperative PROMIS PF subgroups were tested for an association with demographic and perioperative characteristics using 1-way ANOVA or chi-square analysis. Preoperative PROMIS PF subgroups were tested for an association with immediate postoperative pain and narcotics consumption in addition to improvements in PROMIS PF, ODI, SF-12 PCS, and VAS back and leg pain by using linear regression controlling for statistically different demographic characteristics. RESULTS A total of 130 patients were included in this analysis. Patients were grouped by their preoperative PROMIS PF scores: 15.4% had mild disability, 63.8% had moderate disability, and 20.8% had severe disability. There were no significant differences among the subgroups in terms of age, sex, smoking status, and comorbidity burden. Patients with greater disability were more likely to be obese and to have workers' compensation insurance. There were no differences among subgroups in regard to operative levels, operative time, estimated blood loss, and hospital length of stay. Patients with greater disability reported higher VAS pain scores and narcotics consumption for postoperative day 0 and postoperative day 1. Patients with greater preoperative disability demonstrated lower PROMIS PF, ODI, SF-12 PCS, and worse VAS pain scores at each postoperative time point. CONCLUSIONS Patients with worse preoperative disability, as assessed by PROMIS PF, experienced increased pain and narcotics consumption, along with less improvement in long-term PROs. The authors conclude that PROMIS PF is an efficient and accurate instrument that can quickly assess patient disability in the preoperative period and predict both short-term and long-term surgical outcomes.
引用
收藏
页码:476 / 482
页数:7
相关论文
共 50 条
  • [21] Association of Preoperative PROMIS Scores With Short-term Postoperative Improvements in Physical Function After Minimally Invasive Transforaminal Lumbar Interbody Fusion
    Jenkins, Nathaniel W.
    Parrish, James M.
    Brundage, Thomas S.
    Hrynewycz, Nadia M.
    Singh, Kern
    NEUROSPINE, 2020, 17 (02) : 417 - 425
  • [22] Postoperative Narcotic Consumption in Workman's Compensation Patients Following a Minimally Invasive Transforaminal Lumbar Interbody Fusion
    Ahn, Junyoung
    Bohl, Daniel D.
    Elboghdady, Islam
    Aboushaala, Khaled
    Mayo, Benjamin C.
    Hassanzadeh, Hamid
    Singh, Kern
    SPINE, 2015, 40 (16) : 1284 - 1288
  • [23] The Effect of Preoperative Medications on Length of Stay, Inpatient Pain, and Narcotics Consumption After Minimally Invasive Transforaminal Lumbar Interbody Fusion
    Haws, Brittany E.
    Khechen, Benjamin
    Patel, Dil, V
    Bawa, Mundeep S.
    Guntin, Jordan A.
    Cardinal, Kaitlyn L.
    Wiggins, Adam B.
    Singh, Kern
    CLINICAL SPINE SURGERY, 2019, 32 (01): : E37 - E42
  • [24] Improvements in Back and Leg Pain Following a Minimally Invasive Transforaminal Lumbar Interbody Fusion
    Massel, Dustin H.
    Mayo, Benjamin C.
    Narain, Ankur S.
    Hijji, Fady Y.
    Louie, Philip K.
    Jenkins, Nathaniel W.
    Parrish, James M.
    Singh, Kern
    INTERNATIONAL JOURNAL OF SPINE SURGERY, 2020, 14 (05): : 745 - 755
  • [25] PHQ-9 Score Predicts Postoperative Outcomes Following Minimally Invasive Transforaminal Lumbar Interbody Fusion
    Patel, Dil, V
    Yoo, Joon S.
    Khechen, Benjamin
    Haws, Brittany E.
    Block, Andrew M.
    Lamoutte, Eric H.
    Karmarkar, Sailee S.
    Singh, Kern
    CLINICAL SPINE SURGERY, 2019, 32 (10): : 444 - 448
  • [26] Patient-Reported Outcomes of Minimally Invasive versus Open Transforaminal Lumbar Interbody Fusion for Degenerative Lumbar Disc Disease: A Prospective Comparative Cohort Study
    Jover-Mendiola, Antonio D.
    Lopez-Prats, Fernando A.
    Lizaur-Utrilla, Alejandro
    Vizcaya-Moreno, Maria -Flores
    CLINICS IN ORTHOPEDIC SURGERY, 2023, 15 (02) : 257 - 264
  • [27] Comparison of Postoperative Outcomes Between Percutaneous Endoscopic Lumbar Interbody Fusion and Minimally Invasive Transforaminal Lumbar Interbody Fusion for Lumbar Spinal Stenosis
    Lin, Lu
    Liu, Xiao-Qin
    Shi, Lei
    Cheng, Si
    Wang, Zhi-Qiang
    Ge, Qi-Jun
    Gao, Ding-Zhi
    Ismail, Amadou Cheffou
    Ke, Zhen-Yong
    Chu, Lei
    FRONTIERS IN SURGERY, 2022, 9
  • [28] Iliac Crest Bone Graft for Minimally Invasive Transforaminal Lumbar Interbody Fusion A Prospective Analysis of Inpatient Pain, Narcotics Consumption, and Costs
    Haws, Brittany E.
    Khechen, Benjamin
    Narain, Ankur S.
    Hijji, Fady Y.
    Cardinal, Kaitlyn L.
    Guntin, Jordan A.
    Singh, Kern
    SPINE, 2018, 43 (18) : 1307 - 1312
  • [29] The Effect of Morbid Obesity on Complications, Readmission, and Patient-Reported Outcomes Following Minimally Invasive Transforaminal Lumbar Interbody Fusion An Inverse Propensity Score Weighted Analysis
    Claus, Chad F.
    Lawless, Michael
    Lytle, Evan
    Tong, Doris
    Bahoura, Matthew
    Garmo, Lucas
    Gabrail, Joseph
    Bono, Peter
    Kelkar, Prashant
    Richards, Boyd
    Carr, Daniel A.
    Houseman, Clifford
    Soo, Teck M.
    SPINE, 2021, 46 (20) : 1394 - 1401
  • [30] Risk Factors Associated With Failure to Reach Minimal Clinically Important Difference in Patient-reported Outcomes Following Minimally Invasive Transforaminal Lumbar Interbody Fusion for Spondylolisthesis
    Hijji, Fady Y.
    Narain, Ankur S.
    Bohl, Daniel D.
    Yom, Kelly H.
    Kudaravalli, Krishna T.
    Lopez, Gregory D.
    Singh, Kern
    CLINICAL SPINE SURGERY, 2018, 31 (01): : E92 - E97